Pacific Biosciences of Californ

Historical 13F Holders

Symbol
PACB
CUSIP
69404D108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 69404D108 since 12/18/2024, largest first.

Filer % of Class Filed
Price T Rowe Associates Inc /MD/ 13G 10.8% 11/6/2026
Event 10/31/2026
ARK Investment Management LLC 13G/A
9.6% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G/A 7.7% 4/17/2025
Event 3/31/2025
Goldman Sachs Group Inc 13G
7.6% 11/9/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Edmond De Rothschild Asset Management (France) 13G/A
4.5% 7/24/2025
Event 6/30/2025
Madrone Capital Partners, LLC 13G/A
2.8% 11/14/2025
Event 9/30/2025
Millennium Management LLC 13G/A
0.7% 4/9/2025
Event 3/31/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 111 37.2 M $87.9M
2026 Q2 223 191 M $321M
2026 Q1 231 188 M $249M
2025 Q4 221 201 M $374M
2025 Q3 209 186 M $238M
2025 Q2 211 198 M $246M
2025 Q1 227 225 M $266M
2024 Q4 229 260 M $475M
2024 Q3 226 232 M $394M
2024 Q2 234 242 M $332M
2024 Q1 271 266 M $1.01B
2023 Q4 280 281 M $2.76B
2023 Q3 279 263 M $2.20B
2023 Q2 278 254 M $3.37B
2023 Q1 269 253 M $2.93B
2022 Q4 239 225 M $1.84B
2022 Q3 230 212 M $1.23B
2022 Q2 234 225 M $1.03B
2022 Q1 253 223 M $2.03B
2021 Q4 260 205 M $4.20B
2021 Q3 252 189 M $4.83B
2021 Q2 266 173 M $6.04B
2021 Q1 265 164 M $5.47B
2020 Q4 217 170 M $4.42B
2020 Q3 176 149 M $1.47B
2020 Q2 152 109 M $375M
2020 Q1 134 118 M $361M
2019 Q4 144 115 M $592M
2019 Q3 151 118 M $609M
2019 Q2 152 121 M $733M
2019 Q1 162 121 M $873M
2018 Q4 159 107 M $793M
2018 Q3 120 109 M $592M
2018 Q2 100 93.5 M $332M
2018 Q1 102 93.9 M $193M
2017 Q4 109 77.7 M $205M
2017 Q3 99 82.0 M $430M
2017 Q2 107 79.0 M $281M
2017 Q1 108 65.8 M $406M
2016 Q4 117 63.2 M $240M
2016 Q3 131 65.0 M $583M
2016 Q2 144 61.3 M $431M
2016 Q1 134 57.9 M $491M
2015 Q4 122 52.3 M $687M
2015 Q3 90 42.7 M $156M
2015 Q2 102 42.7 M $246M
2015 Q1 94 39.3 M $230M
2014 Q4 102 43.6 M $342M
2014 Q3 89 36.2 M $178M
2014 Q2 86 37.3 M $230M
2014 Q1 87 38.5 M $206M